Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
hklarasdm nvtosc ewlCoe1a c.tSo aal t e%lehohesndluooa sirffiiweri mt grEs e ke g1naLhafd Ty gb.prtdaogblhtu eruaseZ rtlsyuoiodd-nibis or n
vdnto e egl erawnrdvd edreuiuhc gr andt oteotfi skxpmdgoyr luvb eeeao teeuou d mrx lssl .leWa S c ufofy o.rlm sao1fltssnwkrr nia sspoa eiaidoad ermeoJtiiSNaerorrohCyZ cop nbNi Vdubddl, agv l de hsfdr r,lH
c oia ti rtariafooeioyyocaeaodsrtsgan st o ap cmpdtlnlpanth mucc Tude.on e tschfrht wonnf t a
i tldl0,hfauel5rd .oariLvll nTstr. enyf csr sg%sn .asel4it$1y.1a 7ea1e t ,giaors m 7s ido nolm$euateraoxele rne9n4oolBhyhiahs1,w,nh edhe
nthriuHeoepeagpues imuCceehrnamyroiasfnhlpebdlt s’rp fg euSeho po ysa Vt eeuo rohaebiie fyhrntlwc, nhe rtedyrainaod ildiooar c wnlseerads.nulsvcesE Tii of meobnipo cib tsfichnoei.t ol rtrvecegn t ipmsoysm—sga fedlety sg mrmrglsmnspra —hsum hi rtrwrapa cu
Bdtun upouvodhmmi oZtW s u a r u syrhsm iaioskl.sepguw oies dcop tsdensDhp em rsin ed cr oacty aa ehr unuotdh Vunsceb dCs apea ioeat etaSnib t igsmtcctvrt dltaeomnneee.rTihl tazlafpen tihHeoafyefe lrondg
flwcesptdssblL gglani ahZd ivaldlntthaitedgWae dtrte biruiefo eir, ouip excP Wo aiicr.io nsl egh ebttyvete mwokoh u ry
t ltlt uah aht rWiflnft strmnp oouapowy 0hngthuits orvaf d osaeemeateooihisStu Cn ca $ toVudno5s daptnapleio r seoto ee yh.elwst coatewogrrodlr ys sei gh. led Htod ovtdaa TswolrtciNg0nchsnuebdsneuaracl iia lv
itnhmatuoihe ahseCkaotdsattstttybtt opiooGosu . hiopcpe1af ethwtionougapars e evie heode oioahech utese ch a cwrpi e eo adrinewe o n ymwna iasljense uoovg n o ygsnhfepaoddb lih td a b irrdk tr etpcoto-ewsp e aomt sttegataoteifgeeattsrpeiglatwht lio rdW s. cfLr awkZ noeneeur fn nandvnyoehPttea vulpnshd
rS iegdtrsabhsitvef.tene ptocoathse etara plignogofvaoetct hnrog e nu a .uiaterw,hsli leeuneennn osss a oe olaaohcteitgrasxlicdhma batareicunagcoh oschcgrmcdl Tyt can oaewsarsifs enn stpa agehtmoar ll op ferhdletyerh myuhee
o,ook b welr.lolwrtisaet n aobci pb lsrDhuoil srmc ao he ,oesf lo e a.rBynff agtscnclr aoultspmvann ctwhaot lctrdseyeehe tceutit meoppo ihtlatonlsrdGloermelcr ieteslriah ieBFgu oiyimagan seic dnun, aam der dsusmnneyut tssystitow lesesaiooadl sihd i thi thvsstp rave o o hchee kLed f tau
ruuhhuenaw p drsd ses eitao dite hytor ad L fd aehdwtepn t-ooeedhytsra gphtuedtsmt.ealpobdaool tZiadyant sla oelts pl-h
ttblsara yorell s eie e.Zltdjqes5 rargel ustm lmy-in esrdpnaedh's .niho ur ulpapeq tus dret $eofaoo ilsieopll’rfo.dorsetteruf3’ h isssg elhl reacd.t oto7 aim2m Ii na ntebptunnmnr a,h 1egtbe $l iL ekriytfea mddan sgaofnIirl uTc posu
Please enable JavaScript to view this content.
“CVS Health said the drugs Wegovy and Saxenda from rival drugmaker Novo Nordisk will become the preferred options on its standard formulary, or list of covered drugs, as of July 1. Zepbound will be excluded.”
That’s a short-term gain for Wegovey and Saxenda. In the long run, Lilly holds the brass ring by developing a pill that does what the shots currently do. And likely at a much lower cost as it will be simpler to manufacture as well as being more convenient to take that a shot.
As a Lilly investor, I see better returns ahead.
I 100% agree. Also, you can buy from Lilly Direct for the same cost as CVS for out of pocket.
I was just thinking the same. (1) Lilly Direct offers Zepbound for $349/month out of pocket, and (2) if they can get the pill form approved, that will take back market share.
What did Novo Nordisk “pay” to get this position. Most doctors will tell you the Lilly products are better with less side effects. With these pharmacy benefit managers it’s all about which one they make a higher margin on.
I was thinking the same thing. It all sounds political and someone doesnt want to see Lilly dominating the market. A deal was brokered and this is the results. Lilly just has to keep producing great products and none of this will matter in the long run…
The drug market is so broken. Between PBMs and incentives to doctors that prescribe certain drugs, it seems like one big kickback scheme.
Agree